RESOURCES

Browse our content

Posters

Navigating Pitfalls in the Adenovirus Development: From Drug discovery to Clinics and beyond

June 6, 2024

Posters

Revolutionizing mRNA Production: the paradigm-breaking Ntensify™ continuous-batch RNA system 

May 23, 2024

Posters

Tackling AAV Manufacturing Process Industrialization Challenges Using A Standard Platform Approach

May 13, 2024

Webinars

Increasing efficiency in AAV-based gene therapy production: platform optimization with multiserotype AAV affinity capture

April 16, 2024

Articles

CDMO Exothera grows North American tech and footprint

April 8, 2024

Articles

Driving Innovation in Nucleic Acid Therapeutics

April 8, 2024

Webinars

How to achieve high titer cost-effective AAV production

February 6, 2024

Biotech success in 2024

Webinars

Proactive Strategies for Biotech Success in the 2024 Landscape

November 9, 2023

Posters

Online monitoring of cell growth and shape in transient transfection process for AAV production in stirred tank bioreactor

July 4, 2023

Posters

Seamless scale-up of transient transfection process for rAAV production from shake flask to manufacturing-scale bioreactor

June 9, 2023

Webinars

Joint webinar with Bio-Rad Laboratories – Droplet Digital PCR (ddPCR): A Versatile Tool for Absolute Quantification and Quality Analysis of Viral Vector

June 7, 2023

Webinars

Joint webinar with Univercells Technologies – From tech transfer to commercial scale viral manufacturing in 8 months – a CDMO case study

June 1, 2023

Posters

Suspension based adenovirus production in scale-X™️ fixed-bed bioreactor

March 23, 2023

Webinars

Joint webinar with Univercells Technologies – Simplifying Seed Train: A Benchtop System for Intensified Inoculation of Large-Scale Bioreactors

January 24, 2023

Posters

Design of Experiment, a powerful tool to simplify viral production process development

November 28, 2022

Videos

Critical decision to address during the viral vector manufacturing

September 21, 2022

Articles

How standardized viral vector platforms can drive better service from CDMOs

July 12, 2022

Webinars

Joint webinar with Pall Corporations – Pall’s Accelerator℠ Integrated Solutions: Supporting Exothera to meet the high demand for viral vector GMP manufacturing.

June 21, 2022

Podcasts

Using End-to-End Integrated Solutions to meet the High Demand for Viral Vector GMP Manufacturing

June 14, 2022

Webinars

Joint webinar with POLYPLUS – Taking a right first-time approach to optimize end-to-end viral vector manufacturing

June 9, 2022

Reports

Biopharma CDMO Benchmark Report – What customers want from their CDMO

April 15, 2022

Articles

Serum-based media concerns in viral vector manufacturing

March 15, 2022

Articles

Are modern scalable bioreactors the right cell culture strategy for gene and cell therapy success?

January 31, 2022

Articles

Gene and cell therapy manufacturing: how to design your stable cell line strategy?

January 5, 2022

Posters

Adaptation of suspension-based Adenovirus production process to scale-X™ technology

December 21, 2021

White Papers

The landscape for viral vector upstream processes – PROS and CONS

December 11, 2021

Infographics

Timeline of viral vector-based Cell & Gene therapy approvals

May 6, 2021

Infographics

Worldwide approved gene therapies based on viral vectors

February 21, 2021

Infographics

Plasmid manufacturing capacity around the world

November 30, 2020